The Bill & Melinda Gates Foundation and the Pan American Health Organization are working together to make weight loss drugs more accessible in low-income countries.
The Bill & Melinda Gates Foundation and the Pan American Health Organization are working together to make weight loss drugs more accessible in low-income countries.
According to Reuters, these are drugs such as Wegovy from Novo Nordisk and Mounjaro from Eli Lilly.
Paradoxically, about 70% of the approximately 1 billion obese people live in low- and middle-income countries.
In response to a question about methods for solving the problem, Gates assured that his foundation would take any drug that is effective in high-income countries «and figure out how to make it super cheap so that it can get to everyone in the world.»
The publication reminds that starting next year, semaglutide, the active ingredient in Novo Nordisk’s Wegovy drug, will lose its patent in countries such as China and India, so drug manufacturers are already working on inexpensive copies.
Gates noted that his foundation could potentially support clinical trials to test how these drugs affect different populations.
At the same time, as dev.ua wrote, Bill Gates called programming a profession that AI will not replace even in a hundred years.
